Markets:

Overview

News

Currencies

International

Treasuries

Abivax SA - American Depositary Shares (NQ:ABVX)

114.94 +1.33 (+1.17%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Abivax SA - American Depositary Shares

< Previous 1 2 Next >

The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains

December 18, 2025

The financial markets are witnessing a historic "Great Rotation" this December, as the era of defensive posturing and mega-cap concentration appears to be giving way to a broad-based growth rally....

Via MarketMinute

2 Under-the-Radar Stocks That Have Soared This Year ↗

December 09, 2025

These companies are worth your attention.

Via The Motley Fool

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

A late-stage biotech with three pivotal trials underway just landed a major hedge-fund backer — here’s why the timing matters.

Via The Motley Fool

Earnings Outlook For Abivax ↗

August 08, 2025

Via Benzinga

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Amylyx Stock is up a staggering 166% over the past year, and this biotech-focused hedge fund is still doubling down.

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

A biotech specialist doubled down on Dyne ahead of a clinical readout that drew up investor fanfare — and the timing may be the entire story.

Via The Motley Fool

Topics Regulatory Compliance

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

A science-first biotech fund just sized up its stake in an ALS-focused company heading into a pivotal year for the firm.

Via The Motley Fool

Topics Regulatory Compliance

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of commercialization.

Via The Motley Fool

Topics Regulatory Compliance

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

A science-first biotech fund is leaning deeper into one company just as its lead program delivers some compelling early neuro data.

Via The Motley Fool

Topics Regulatory Compliance

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

One biotech-focused investment firm cashed out of its stake in this drug developer as the stock soared—but seemingly missed out on a massive premium by mere weeks.

Via The Motley Fool

This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

November 06, 2025

Via Benzinga

Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗

October 09, 2025

Via Benzinga

AMD To Rally More Than 47%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 07, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Why Is Abivax Stock Trading Higher On Monday? ↗

October 06, 2025

Abivax said Phase 3 trials showed obefazimod improved clinical outcomes in ulcerative colitis, meeting key endpoints with no new safety concerns.

Via Benzinga

Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease ↗

October 06, 2025

The company is working on a treatment for a form of inflammatory bowel disease, a highly watched disease area.

Via Investor's Business Daily

Topics Government

RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

September 12, 2025

Via Benzinga

Market Movers: Robinhood, AppLovin Surge into S&P 500 Amidst Crucial Earnings Season

September 08, 2025

The financial markets are abuzz with significant corporate developments as several key companies navigate pivotal moments, ranging from prestigious S&P index inclusions to critical quarterly earnings...

Via MarketMinute

Topics Artificial Intelligence ETFs Retirement

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

This Stock Is Up by 800% This Year -- but Is It a Buy? ↗

July 31, 2025

This little-known biotech might still deliver strong returns.

Via The Motley Fool

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

July 25, 2025

Via Benzinga

Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday ↗

July 23, 2025

Via Benzinga

Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings ↗

July 23, 2025

Via Benzinga

Topics Stocks

Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results ↗

July 23, 2025

The results represent a best-case scenario for the company in treating inflammatory bowel disease, according to one analyst.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

Abivax Stock Skyrockets On Strong Data From Inflammatory Bowel Disorder Study ↗

July 23, 2025

Abivax shares jump as obefazimod meets key Phase 3 trial endpoints in ulcerative colitis with strong remission rates and a favorable safety profile.

Via Benzinga

Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket ↗

July 23, 2025

Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions